Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites?
- 1 January 1998
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 58 (1) , 39-54
- https://doi.org/10.1016/s0952-3278(98)90128-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Effect of dietary fat on diethylnitrosamine induced hepatocarcinogenesis in Wistar ratsCancer Letters, 1995
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistanceInternational Journal of Cancer, 1994
- Effects of Exogenous Lipids on Cancer and Cancer ChemotherapyDrug Safety, 1993
- Reversal of multidrug resistance by B859-35, a metabolite of B859-35, niguldipine, verapamil and nitrendipineZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Stimulation of free radical generation in human leukocytes by various agents including tumor necrosis factor is a calmodulin dependent processBiochemical and Biophysical Research Communications, 1990
- Level of protein kinase C activity correlates directly with resistance to adriamycin in murine fibrosarcoma cellsFEBS Letters, 1989
- Activation of rat brain protein kinase C by lipid oxidation productsBiochemical and Biophysical Research Communications, 1988
- Vitamin E inhibits protein kinase c activityBiochemical and Biophysical Research Communications, 1988
- Free radicals as possible mediators of the actions of interferonJournal of Free Radicals in Biology & Medicine, 1986